2009
DOI: 10.1016/j.jpeds.2008.07.042
|View full text |Cite
|
Sign up to set email alerts
|

Predictors of Response to Proton Pump Inhibitor Therapy among Children with Significant Esophageal Eosinophilia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

12
141
0
6

Year Published

2013
2013
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 139 publications
(159 citation statements)
references
References 24 publications
12
141
0
6
Order By: Relevance
“…Current thinking suggests that eosinophilic oesophagitis is an immune-mediated, antigen-driven disorder; 3 thus, diet elimination and/or corticosteroid therapy would seem the fitting therapeutic strategy. 4 There is now, however, confirmatory evidence available, including our study 2 and their data, 5,6 as well as other studies, [7][8][9][10][11][12][13][14][15] that symptomatic patients with oesophageal eosinophilic infiltration, which is phenotypically indistinguishable from eosinophilic oesophagitis, respond to PPI therapy. In further support of Drs.…”
supporting
confidence: 79%
See 2 more Smart Citations
“…Current thinking suggests that eosinophilic oesophagitis is an immune-mediated, antigen-driven disorder; 3 thus, diet elimination and/or corticosteroid therapy would seem the fitting therapeutic strategy. 4 There is now, however, confirmatory evidence available, including our study 2 and their data, 5,6 as well as other studies, [7][8][9][10][11][12][13][14][15] that symptomatic patients with oesophageal eosinophilic infiltration, which is phenotypically indistinguishable from eosinophilic oesophagitis, respond to PPI therapy. In further support of Drs.…”
supporting
confidence: 79%
“…Studies validating these findings come from geographically diverse centres across both sides of the Atlantic 2, 5, 9 and Asia. 10 The benefits are noted in both children 7,8,12 and adult populations. 2,5 The magnitude of the response rates is robust (at least 33%, and as much as 75%).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…High dose PPI with anti-reflux measures are useful in treating patients with esophageal eosinophilia secondary to GERD, PPI-REE, and EoE [45,46]. In patients found to have esophageal eosinophilia it is recommended to give a PPI once or twice daily for 8 to 12 weeks in adults and 1 mg/kg per dose, twice daily for 8 to 12 weeks in children.…”
Section: Therapymentioning
confidence: 99%
“…(40my BID for 2 weeks). The focus on exclusion of PPI-REE was because it can easily be misdiagnosed as EoE and because it was found to constitute up to 30% of EoE family [9,10].…”
Section: Mini Reviewmentioning
confidence: 99%